The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats

Shock

Volumn 31, Issue 3, 2009, Pages 322-329

  Huang, Li Feng ^a   Yao, Yong Ming ^a   Zhang, Li Tian ^a   Dong, Ning ^a   Yu, Yan ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

cell polarization; cytokines; Cytotoxic T lymphocyte associated antigen 4; forkhead winged helix transcription factor p3; proliferation

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MESSENGER RNA; RECEPTOR ANTIBODY; TRANSCRIPTION FACTOR FOXP3; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIBODY; CYTOKINE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, RAT; HBP1 PROTEIN, RAT; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; REPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; THERMAL INJURY; ANIMAL; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; TIME; WISTAR RAT;

ANIMALS; ANTIBODIES; ANTIGENS, CD; BURNS; CELL PROLIFERATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HIGH MOBILITY GROUP PROTEINS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; PYRUVATES; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC; REPRESSOR PROTEINS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 62449182540     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181834070     Document Type: Article

References (36)

1. Sakaguchi S: Naturally arising CD4+ regulatory T cells for immunologic self- tolerance and negative control of immune responses. Annu Rev Immunol 22: 531-562. 2004.
2. Roncarolo MG, Bacchetta R, Bordignon C. Narula S, Levings MK: Type 1 T regulatory cells. Immunol Rev 182:68-79, 2001.
3. Zhai Y, Kupiec-Weglinski JW: What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 11:497-503, 1999.
4. Shevach EM: CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389-400, 2002.
5. Ramsdell F: Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19:165-168, 2003.
6. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hangers FC, Elferink BG, van der Zanden L, de Vries RR, Huizinga TW. et al.: Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol 66:13-20, 2005.
7. O'Garra A, Vieira PL, Vieira P, Goldfeld AE: IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378, 2004.
8. Mills KH: Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4:841-855, 2004.
9. Belkaid Y, Rouse BT: Natural regulatory T cells in infectious disease. Nature Immunol 6:353-360, 2005.
10. Efron P, Moldawer LL: Sepsis and the dendritic cell. Shock 20:386-401. 2003.
11. Thomas JO, Travers AA: HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 26:167-174, 2001.
12. Sunden-Cullberg J, Norrby-Teglund A. Treutiger CJ: The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis 19:231-236, 2006.
13. Chen G, Li J, Ochani M, Rendon-Mitchell B, Qiang X, Susarla S, Ulloa L, Yang H, Fan S, Goyert SM, et al.: Bacterial endotoxin stimulates macrophages to release HMGB1 artly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76:994-1001, 2004.
14. Semino C, Angelini G, Poggi A, Rubartelli A: NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106:609-616, 2005.
15. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ: High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81:59-66, 2007.
16. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274:19919-19924, 1999.
17. Das UN: Is pyruvate an endogenous anti-inflammatory molecule? Nutrition 22:965-972, 2006.
18. Zhang LT, Yao YM, Dong YQ, Dong N, Yu Y, Sheng ZY: Relationship between high mobility group box-1 protein release and T cell suppression in rats after thermal injury. Shock 30:449-455, 2008.
19. H2 response in islet xenograft rejection. Diabetes 51:79-86, 2002.
20. Kim HY, Kim HJ, Min HS, Kim S, Park WS, Park SH, Chung DH: NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor betal production. J Exp Med 201:41-47, 2005.
21. Maizels RM: Infections and allergy - helminths, hygiene and host immune regulation. Curr Opin Immunol 17:656-661, 2005.
22. Murphy TJ, Ni Choileain N, Zang Y, Mannick JA, Lederer JA: CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 174:2957-2963, 2005.
23. Marie JC, Letterio JJ, Gavin M, Rudensky AY: TGF-βl maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201:1061-1067, 2005.
24. Pestka S. Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB: Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929-979, 2004.
25. Patenaude J, D'Elia M, Hamelin C, Garrel D, Bernier J: Burn injury induces a change in T cell homeostasis affecting preferentially CD4+ T cells. J Leukoc Biol 77:141-150, 2005.
26. Mantell LL, Parrish WR, Ulloa L: HMGB-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25:4-11, 2006.
27. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 99: 12351-12356, 2002.
28. Zhang Y, Yao YM, Dong N, Yu Y, Sheng ZY: Influence of high mobility group box-1 protein on immunosuppression molecules expression of splenic regulatory T cells in mice. Chin J Exp Surg 24:616-618, 2007.
29. Huang LF, Yao YM, Meng HD, Zhao XD, Dong N, Yu Y, Sheng ZY: The effects of high mobility group box-1 protein on immune function of human T lymphocytes in vitro. Chin Crit Care Med 20:7-13, 2008.
30. Yamada S, Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta 375:36-42, 2007.
31. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, Bachi A, Rubartelli A, Agresti A, Bianchi ME: Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551-5560, 2003.
32. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 61:1-9, 2005.
33. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377, 2004.
34. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299:1033-1036, 2003.
35. Phan HH, Cho K, Nelson HA, Shin S, Jeong J, Greenhalgh DG: Down- regulation of NF-kappaB activity associated with alteration in proliferative response in the spleen after burn injury. Shock 23:73-79, 2005.
36. Sun Z, Andersson R: NF-kappaB activation and inhibition: a review. Shock 18:99-106, 2002.